FDA Clearance Tracker · P970004-S023
MEDTRONIC INTERSTIM THERAPY FOR URINARY CONTROL STIMULATON DESKTOP SOFTWARE
Last checked: Nov 20, 2026Latest source record: Jan 23, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Jan 23, 2003
Approved
Time to decision
176 days
Received Jul 31, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970004-S023
- Device name
- MEDTRONIC INTERSTIM THERAPY FOR URINARY CONTROL STIMULATON DESKTOP SOFTWARE
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Jul 31, 2002
- Decided
- Jan 23, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970004
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE MODEL 8870 INTERSTIM APPLICATION SOFTWARE TO OPERATING ON THE MODEL 8840 CLINICIAN PROGRAMMER, USE OF ENHANCED STIMULATION DESKTOP SOFTWARE, AN EXPANDED MEMORY CARD STORAGE, AND UPDATED LABELING. THESE CHANGES ARE USED WITH THE MEDTRONIC INTERSTIM THERAPY FOR URINARY CONTROL, WHICH IS INDICATED FOR THE TREATMENT OF URINARY RETENTION AND THE SYMPTOMS OF OVERACTIVE BLADDER, INCLUDING URINARY URGE INCONTINENCE AND SIGNIFICANT SYMPTOMS OF URGENCY-FREQUENCY ALONE OR IN COMBINATION, IN PATIENTS WHO HAVE FAILED OR COULD NOT TOLERATE MORE CONSERVATIVE TREATMENTS.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.